**
A substantial criminal operation trafficking illegal steroids and unapproved medications has been dismantled by the Medicines and Healthcare products Regulatory Agency (MHRA), culminating in the sentencing of seven men. The investigation unearthed over 130,000 doses of various substances, including well-known drugs like tamoxifen and finasteride, raising significant public health concerns regarding the safety of unregulated pharmaceuticals.
Unveiling a Criminal Operation
The crackdown stems from a comprehensive investigation initiated by the MHRA’s Criminal Enforcement Unit, which traced a suspected online sales platform linked to the Bolton area. This platform was reportedly involved in distributing performance-enhancing steroids and other illicit medicines. Investigators pinpointed a flat above commercial premises on St Helens Road in Bolton as the central hub where these drugs were stored, packaged, and dispatched.
The operation’s scale is alarming; the illegal supply network was estimated to be worth £1.8 million. Charges against the men included conspiracy to supply controlled drugs and money laundering, resulting in a collective prison sentence exceeding 21 years.
Profile of the Offenders
Among those sentenced, Zaheer Oomer, who is currently unemployed, accepted responsibility early in the investigation, admitting to money laundering offences amounting to £99,893. Other defendants included Rizwan Atcha, a health and safety advisor, and Imtiaz Atcha, a former bank manager, both of whom pleaded guilty to laundering substantial sums of money linked to the operation.
Three additional men—Abdul Khan, Saddym Shahid, and Rajendra Patel—initially denied the charges but were found guilty following a trial at Bolton Crown Court. They faced significant money laundering accusations, with amounts ranging from £139,967 to £248,750. The guilty verdicts, reached on 7 July 2025, highlight the extent of the criminal activities and the collaborative efforts of law enforcement agencies.
The Health Risks of Unregulated Medications
Tim Duffield, the MHRA’s Head of Intelligence, stated, “This was a well-organised operation that put people at real risk. Medicines bought outside regulated channels can be unsafe, ineffective or fake.” Such warnings are echoed by health authorities, underscoring the dangers associated with purchasing anabolic steroids and other prescription-only medications from unverified sources. The NHS has cautioned that misuse can lead to severe health complications, including addiction and permanent bodily harm.
The recent findings also coincide with troubling data regarding counterfeit and unlicensed weight loss products. Over the past three years, authorities have confiscated more than 6,500 unapproved weight loss injections in the UK. In a particularly concerning case, drugs were discovered at a farm in Lincolnshire linked to a network producing and selling counterfeit injections, raising fears about public safety.
The Broader Implications for Public Health
The MHRA has consistently urged consumers to procure medications solely from credible and regulated outlets, such as licensed pharmacies. The illegal steroid market not only jeopardises individual health but also poses a broader societal threat by normalising the use of unregulated substances, particularly among young people and athletes.
Mario Theophanous, Head of Intelligence and Investigations at UK Anti-Doping (UKAD), emphasised the importance of dismantling such networks: “Disrupting the supply of illegal performance-enhancing drugs is central to protecting sport. Our intelligence officers work in partnership with regulators and law enforcement to identify and dismantle the criminal networks that make these substances available.”
Why it Matters
The dismantling of this extensive illegal steroids network highlights a critical intersection of public health and criminal justice. As the rise of counterfeit and unregulated medications continues to threaten consumer safety, the need for rigorous enforcement and public education becomes paramount. The implications extend beyond individual health risks; they raise significant questions about the efficacy of current regulation in safeguarding public health, particularly in an era where access to medications is increasingly facilitated by online platforms. Ensuring that individuals are informed about the perils of unregulated substances is essential in combating this growing crisis.
